Serum zinc as a biomarker to predict the efficacy of immune checkpoint inhibitors in cancers
Saved in:
| Main Authors: | Jingliang Wang, Weihao Wang, Bin Liu, Rui Zhao, Jing Zhao, Fengxian Jiang, Wei Xu, Zhizhao Zhang, Pancen Ran, Yang Shu, Yahui Wang, Liying Pan, Lei Liu, Fang Luan, Guobin Fu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12225854/?tool=EBI |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The efficacy of immunotherapy in non-small cell lung cancer with KRAS mutation: a systematic review and meta-analysis
by: Rui Zhao, et al.
Published: (2024-11-01) -
PLK1 in cancer therapy: a comprehensive review of immunomodulatory mechanisms and therapeutic opportunities
by: Weihao Wang, et al.
Published: (2025-06-01) -
Serum cytokines as a biomarker for immune checkpoint inhibitor toxicity in patients with pleural mesothelioma
by: Saima Jamil Farooqi, et al.
Published: (2024-12-01) -
Current Status of Immune Checkpoint Inhibitors and Treatment Responsive Biomarkers for Triple‐Negative Breast Cancer
by: Xinran Wang, et al.
Published: (2025-05-01) -
Predictive biomarkers for immune checkpoint inhibitors therapy in lung cancer
by: Jie Yao, et al.
Published: (2024-12-01)